Absci (ABSI) shares were more than 17% lower pre-bell Friday after the company said late Thursday it priced a $50 million stock offering.
Centene (CNC) stock was down 12%, a day after the company reported it swung to a Q2 adjusted loss.
Sarepta Therapeutics (SRPT) shares were nearly 12% lower after the Brazilian Health Regulatory Agency late Thursday temporarily suspended the company's gene therapy drug Elevidys.
OneConstruction Group (ONEG) stock was down 14%, erasing Thursday's gains.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.